Clari Vest Asset Management LLC Avrobio, Inc. Transaction History

Clari Vest Asset Management LLC

  • $1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 09, 2021
SELL
$7.84 - $12.6 $181,888 - $292,320
-23,200 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$10.54 - $19.3 $12,647 - $23,160
1,200 Added 5.45%
23,200 $294,000
Q4 2020

Feb 09, 2021
SELL
$12.79 - $17.1 $2,558 - $3,420
-200 Reduced 0.9%
22,000 $307,000
Q3 2020

Nov 09, 2020
BUY
$12.99 - $19.41 $36,372 - $54,348
2,800 Added 14.43%
22,200 $289,000
Q2 2020

Aug 12, 2020
BUY
$12.19 - $22.96 $236,486 - $445,424
19,400 New
19,400 $338,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email